536 results match your criteria: "University of the Sciences in Philadelphia[Affiliation]"
Am J Health Syst Pharm
August 2001
University of the Sciences in Philadelphia, Philadelphia College of Pharmacy, Philadelphia, PA 19104-4495, USA.
Artif Cells Blood Substit Immobil Biotechnol
July 2001
Department of Pharmaceutics, University of the Sciences in Philadelphia, PA 19104, USA.
A cross-linked hemoglobin membrane has been created with discerning permeability between dissolved hemoglobin and small molecules. Such a membrane could be used to enclose a sphere of hemoglobin solution thereby allowing the entire "cell" to transport oxygen. The hemoglobin membrane was cross-linked on a polycarbonate support; the mechanical support was necessary for diffusion experiments in this study and would not be used during any sphere preparation.
View Article and Find Full Text PDFAm J Manag Care
July 2001
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, 600 South 43rd Street, Philadelphia, PA 19104-4495, USA.
Objective: To examine advantages of and obstacles to electronic prescribing in the ambulatory care environment.
Data Sources: MEDLINE and International Pharmaceutical Abstract searches were conducted for the period from January 1980 to September 2000. Key words were electronic prescribing, computerized physician order entry, prior authorization, drug utilization review, and consumer satisfaction.
Bioorg Med Chem Lett
July 2001
Department of Chemistry & Biochemistry, University of the Sciences in Philadelphia, 19104, Philadelphia, PA, USA.
A series of compounds bearing an endocyclic -N-O- moiety with potential antimalarial activity based on simple derivatives of the tropolone purpurogallin was prepared by means of a hetero Diels-Alder reaction using nitrosobenzene as a dienophile. The rationale behind the design of these compounds is presented, together with the synthetic route to derivatives bearing aromatic and aliphatic esters of the C4'-position hydroxyl group of the purpurogallin framework, as well as biological data obtained from in vitro assays against Plasmodium falciparum and Trypanosoma cruzi. Several of the new compounds have activities in the 3-9 microM range, and provide leads for the development of a novel class of antiparasitic drugs with improved biological and pharmacological properties.
View Article and Find Full Text PDFPharm Dev Technol
November 2001
Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, PA 19104, USA.
The objective of this study was to evaluate the effects of processing methods and heat treatment on matrix formation and subsequent drug release from wax matrix tablets for controlled release. Phenylpropanolamine hydrochloride (PPA) and Compritol were processed with appropriate diluent(s) using either dry blending (DB), wet granulation (WG), partial melt granulation (PMG), or melt granulation (MG). Then the tablets were heat-treated at 80 degrees C.
View Article and Find Full Text PDFDrug Dev Ind Pharm
April 2001
University of the Sciences in Philadelphia, PA 19104, USA.
The moist granulation technique (MGT), which involves agglomeration and moisture absorption, has only been applied to immediate-release dosage forms. Our results indicate that MGT appears to be applicable in developing a controlled-release formulation. A small amount of granulating fluid (water) was added to a powder blend to activate a dry binder (such as polyvinylpyrrolidone [PVP] at 2% and 3.
View Article and Find Full Text PDFPharmacotherapy
June 2001
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Pennsylvania, USA.
Therapy for acute myocardial infarction involves rapid restoration of blood flow through a coronary artery that has been occluded by a ruptured atherosclerotic plaque. Thrombolytic therapy, the pharmacologic standard to achieve this outcome, significantly improves survival; however, current regimens have limitations: they can fail to achieve complete reperfusion, they can cause significant bleeding events, and they can result in reocclusion. In addition, complex regimens of some agents can cause dosing errors.
View Article and Find Full Text PDFToxicol In Vitro
June 2001
Department of Pharmaceutical Sciences, University of the Sciences in Philadelphia, 600 South 43rd Street, PA 19104-4495, Philadelphia, USA.
Alamar blue and MTT are indicators used to measure cytotoxicity of various chemicals in cultured cells. Both Alamar blue and MTT are reduced by mitochondrial enzymes. We observed enhanced fluorescence of Alamar blue when kidney epithelial cells were co-incubated with hepatic post-mitochondrial supernatant (S9) fractions as compared with cells incubated in the absence of S9 fractions.
View Article and Find Full Text PDFAnn Pharmacother
May 2001
Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA, USA.
Objective: To review literature relating to significant changes in drug therapy recommendations in the 1999 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for treating patients with acute myocardial infarction (AMI).
Data Sources: 1999 ACC/AHA AMI guidelines, English-language clinical trials, reviews, and editorials researching the role of drug therapy and primary angioplasty for AMI that were referenced in the guidelines were included. Additional data published in 2000 or unpublished were also included if relevant to interpretation of the guidelines.
Ann Pharmacother
April 2001
University of the Sciences in Philadelphia, Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, PA 19104-4495, USA.
Objective: To review recent clinical trials that evaluate the most appropriate therapeutic options for delaying the progression of nephropathy in type 2 diabetic patients.
Data Sources: Primary and review articles were retrieved through a MEDLINE search (January 1990-January 2000).
Study Selection And Data Extraction: All studies related to attenuating the progression of nephropathy in diabetic patients were evaluated and included in this review.
J Am Pharm Assoc (Wash)
May 2001
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA 19104-4495, USA.
Objective: To provide information regarding the most important properties of the new therapeutic agents marketed in 2000.
Data Sources: Published studies, drug information reference sources, and product labeling.
Data Synthesis: In 2000, 33 new therapeutic agents were marketed.
J Am Pharm Assoc (Wash)
May 2001
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA 19104, USA.
Objective: To determine whether differences in the provision of pharmacy services exist among different types of Internet pharmacies.
Design: Survey of selected pharmacies with a presence on the Internet. Data were abstracted onto a data collection form for further analysis.
J Chromatogr A
March 2001
Department of Chemistry/Biochemistry, University of the Sciences in Philadelphia, PA 19104, USA.
An HPLC method was developed for quick scanning of taxanes from large numbers of plant cell suspension samples. The method was optimized for analysis of a range of taxanes of differing polarity. Identification of a standard mixture of paclitaxel and 12 related taxanes was achieved in less than 15 min using a gradient mode and a Microsorb-MV C8 column.
View Article and Find Full Text PDFAnn Pharmacother
March 2001
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA, USA.
Ann Pharmacother
March 2001
Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA 19104-4495, USA.
Objective: To report a case of bradycardia secondary to atrioventricular nodal block (AVNB) successfully treated with intravenous theophylline. Intravenous theophylline was used as an alternative to temporary pacing in a patient with sepsis secondary to thermal injury.
Case Summary: A 79-year-old white woman with significant cardiac history was admitted with 14.
Pharmacotherapy
March 2001
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Pennsylvania 19104, USA.
Int J Pharm
March 2001
Department of Pharmaceutical Sciences, University of the Sciences in Philadelphia, PA 19104, USA.
Microencapsulated phenylalanine ammonia lyase (PAL) exhibits a marked reduction in activity compared to the activity of the free enzyme in pH 8.5 Tris buffer. The purpose of this investigation was to evaluate the contribution of incomplete entrapment, the internal environment of cellulose nitrate membrane microcapsules, the diffusional barrier of the membrane and the microcapsulation process to the low activity of encapsulated PAL.
View Article and Find Full Text PDFPharm Dev Technol
May 2001
Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, 600 S. Forty-third Street, Philadelphia, PA 19104, USA.
A novel method for measuring gel strength of hydrogel controlled release (CR) tablets is presented. CR tablets containing hydroxypropyl methylcellulose (HPMC) were fixed to a glass plate, placed in a dissolution apparatus, and subjected to dissolution conditions corresponding to 50% drug release. Tablets were then removed from the dissolution apparatus without disturbing the swollen (gel) layer.
View Article and Find Full Text PDFJ Orthop Sports Phys Ther
February 2001
Department of Physical Therapy, University of the Sciences in Philadelphia, PA. 19104-4495, USA.
Study Design: Test-retest repeated measures and correlational design.
Objectives: To examine the reliability and validity of a "modified" digital inclinometer to assess scapular upward rotation during humeral elevation in the scapular plane
Background: Evidence exists that scapular motion is related to shoulder pathology; however, evaluation and treatment planning for shoulder rehabilitation often fails to include an objective assessment of scapular motion.
Methods And Measures: Two-dimensional measurements by the inclinometer were taken with the arm in a static position.
Nat Biotechnol
March 2001
Department of Chemistry and Biochemistry, University of the Sciences in Philadelphia, 600 S. 43rd Street, Philadelphia, PA 19104-4495, USA.
Clin Ther
January 2001
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Pennsylvania 19104, USA.
Background: Since its approval by the US Food and Drug Administration in March 1998, sildenafil citrate has been used by millions of men for the treatment of erectile dysfunction. Recent studies and consensus reports have expanded our understanding of its efficacy, safety, contraindications, and drug interactions.
Objective: This paper reviews recent studies of the efficacy of sildenafil, its adverse effects and drug interactions, and socioeconomic factors involved in its use, with a focus on specific patient populations (prostate cancer, diabetes mellitus, ischemic heart disease, spinal cord injuries, neurologic disorders).
Nursing
January 2001
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, Pa., USA.
Ann Pharmacother
January 2001
Department of Pharmacy Practice and Pharmacy Administration, University of the Sciences in Philadelphia, 600 S. 43rd St., Philadelphia, PA 19104-4495, USA.
Pharm Res
October 2000
Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA 19104, USA.
Purpose: Our laboratory has previously prepared gelatin/ methotrexate (MTX) conjugates containing mixed conjugation sites and by-product crosslinking, both of which may alter conjugate effectiveness. In this study, we prepared and evaluated gelatin/MTX conjugates having specific conjugate bond sites and minimal by-product crosslinking.
Methods: Opposite polarity conjugates were produced by coupling gelatin having blocked amino groups with MTX (G-MTX) and by coupling MTX having blocked amino groups with gelatin (M-GEL) using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide HCl.
Ther Drug Monit
December 2000
Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA, USA.
This prospective study was conducted to compare the predictive performance of fluorescence polarization immunoassay (FPIA, Abbott TDx Digoxin II) and radioimmunoassay (RIA, Kallestad Labs) with combined low-pressure liquid chromatography/RIA (LPLC/RIA) digoxin assay in measuring 15-17 serum digoxin concentrations (SDC) obtained after a single 10 microg/kg intravenous digoxin dose in patients with various degrees of renal function and at different SDC ranges. Eighteen men and women were stratified into 3 age- and gender-matched groups based upon renal function [N = 6 in each, group I (Cl(cr) < 10 mL/min), group II (Cl(cr) = 10-50 mL/min), and group III (Cl(cr) > 50 mL/min)]. Serum digoxin concentrations were measured at time zero; at 0.
View Article and Find Full Text PDF